Patent 8003621 was granted and assigned to Nitto Denko on August, 2011 by the United States Patent and Trademark Office.
Compositions that can include a cationic polymeric carrier, targeting agent, and therapeutic agent are disclosed herein. The therapeutic agent may have a therapeutic activity such as inhibiting fibrosis within a target organ or tissue or inhibiting the growth of a cancer cell.